Stryker vs. Zimmer Biomet vs. Johnson and Johnson: How they compare in Q1 2024
Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2024 and data on their orthopedic sales.
Stay updated with breaking news from Ohnson Amp Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2024 and data on their orthopedic sales.
Plus, Weight loss drugs are so hot that Eli Lilly is expecting $2 billion more in sales this year
Plus, a key Boeing supplier is teasing a solution to its production woes
Media contact:Sophie DaneauSdaneau@its.jnj.com+33 6 3178 8798Investor contact:Raychel Kruperinvestor-relations@its.jnj.com For European and UK...
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer, pending approval of the claimants.